Hospital Universitari Germans Trias i Pujol, Barcelona, Spain.
Clin Exp Rheumatol. 2011 Mar-Apr;29(2):331-6. Epub 2011 Apr 19.
To describe the clinical, laboratory and radiological features, treatment and prognosis of patients with adult onset Still's disease (AOSD).
Specific clinical features were retrospectively recorded in 41 patients fulfilling the Yamaguchi criteria. Patients were reviewed in two academic hospitals with a referral area of 700,000-1,000,000 inhabitants. Laboratory tests including haemogram, ferritin, biochemistry and autoimmunity were reviewed. Radiological studies, treatment and ACR functional class were determined.
Forty-one patients with AOSD were identified, 25 of whom were female. Mean age at diagnosis: 38.19 years (range 17-68). Feverish polyarthritis was the most common clinical presentation. Acute phase reactants were invariably high in all patients. Serum ferritin levels were elevated in 86% of patients. Anti-cyclic citrullinated peptide antibodies (anti-CCP antibodies) were negative in all patients except one. The course of the disease was monocyclic in 44% of the patients, polycyclic in 26%, and chronic articular in 30%. ACR class was as follows: 29 (72.5%) class I, 7 (17.5%) class II, 2 (5%) class III and 2 (5%) class IV. As for the treatment received, aspirin or NSAIDs controlled the disease in eight patients (19.5%) and high-dose corticosteroids (0.5-1 mg/kg/day) in 32 (78%). Almost half of the patients (49%) required an additional diseasemodifying agent, usually methotrexate. Finally, in seven of them (17%) a biological treatment with TNF-α or specially anti-IL-1 had to be added to control the disease.
The clinical and laboratory findings were similar to previous studies. Anti-CCP antibodies were almost always negative. A monocyclic course was associated with a good prognosis. Most of the patients were in ACR functional class I and II. Biological agents were required in 7 patients (17%).
描述成人斯蒂尔病(AOSD)患者的临床、实验室和影像学特征、治疗方法和预后。
回顾性记录了符合 Yamaguchi 标准的 41 例患者的特定临床特征。在两家学术医院对患者进行了回顾性研究,其转诊区域的居民人数为 70 万至 100 万。回顾了血液学检查、铁蛋白、生化和自身免疫检查。确定了影像学研究、治疗方法和 ACR 功能分类。
共确定了 41 例 AOSD 患者,其中 25 例为女性。诊断时的平均年龄为 38.19 岁(范围 17-68 岁)。发热性多发性关节炎是最常见的临床表现。所有患者的急性期反应物均始终升高。86%的患者血清铁蛋白水平升高。除 1 例外,所有患者的抗环瓜氨酸肽抗体(抗 CCP 抗体)均为阴性。44%的患者疾病呈单周期,26%的患者呈多周期,30%的患者呈慢性关节病。ACR 分类如下:29 例(72.5%)为 I 类,7 例(17.5%)为 II 类,2 例(5%)为 III 类,2 例(5%)为 IV 类。至于接受的治疗,阿司匹林或 NSAIDs 控制了 8 例(19.5%)患者的疾病,高剂量皮质类固醇(0.5-1mg/kg/天)控制了 32 例(78%)患者的疾病。近一半的患者(49%)需要额外的疾病修饰剂,通常是甲氨蝶呤。最后,在其中 7 例(17%)患者中,需要添加 TNF-α 或特别抗 IL-1 的生物治疗来控制疾病。
临床和实验室发现与以往研究相似。抗 CCP 抗体几乎总是阴性。单周期病程与良好的预后相关。大多数患者处于 ACR 功能分类 I 类和 II 类。7 例(17%)患者需要使用生物制剂。